Your browser is no longer supported. Please, upgrade your browser.
SYK Stryker Corporation monthly Stock Chart
Stryker Corporation
IndexS&P 500 P/E33.94 EPS (ttm)5.70 Insider Own0.10% Shs Outstand374.80M Perf Week-2.78%
Market Cap75.15B Forward P/E21.86 EPS next Y8.84 Insider Trans-9.86% Shs Float347.47M Perf Month5.15%
Income2.16B PEG7.21 EPS next Q1.36 Inst Own74.40% Short Float0.99% Perf Quarter7.02%
Sales14.96B P/S5.02 EPS this Y4.60% Inst Trans-0.07% Short Ratio2.10 Perf Half Y-8.26%
Book/sh34.99 P/B5.52 EPS next Y39.06% ROA7.40% Target Price206.86 Perf Year-9.21%
Cash/sh10.41 P/C18.57 EPS next 5Y4.71% ROE16.60% 52W Range124.54 - 226.30 Perf YTD-7.93%
Dividend2.30 P/FCF98.37 EPS past 5Y32.40% ROI9.30% 52W High-15.05% Beta0.86
Dividend %1.19% Quick Ratio1.80 Sales past 5Y9.00% Gross Margin65.70% 52W Low54.37% ATR5.60
Employees40000 Current Ratio2.60 Sales Q/Q2.00% Oper. Margin18.10% RSI (14)50.51 Volatility2.87% 2.50%
OptionableYes Debt/Eq0.80 EPS Q/Q19.50% Profit Margin13.90% Rel Volume0.58 Prev Close193.30
ShortableYes LT Debt/Eq0.72 EarningsJul 30 AMC Payout37.40% Avg Volume1.64M Price192.25
Recom2.10 SMA201.48% SMA501.42% SMA200-1.01% Volume613,068 Change-0.54%
Apr-13-20Downgrade Barclays Equal Weight → Underweight $155
Apr-01-20Downgrade Goldman Buy → Sell $248 → $150
Mar-05-20Initiated Citigroup Buy $235
Feb-13-20Initiated Goldman Buy $248
Jan-08-20Initiated SunTrust Hold $217
Jan-07-20Downgrade Piper Sandler Overweight → Neutral $210
Jan-07-20Downgrade Piper Jaffray Overweight → Neutral $210
Dec-30-19Reiterated BTIG Research Buy $228 → $236
Nov-05-19Downgrade Barclays Overweight → Equal Weight $226 → $207
Oct-30-19Reiterated BofA/Merrill Buy $220 → $245
Jul-02-19Downgrade Evercore ISI Outperform → In-line
Jan-30-19Reiterated Canaccord Genuity Buy $185 → $190
Jan-03-19Initiated Deutsche Bank Buy $179
Jan-02-19Upgrade Evercore ISI In-line → Outperform
Oct-16-18Initiated Barclays Overweight $198
Aug-16-18Initiated BTIG Research Buy $187
Jun-27-18Initiated Bernstein Mkt Perform $177
Apr-27-18Reiterated Stifel Buy $183 → $187
Apr-27-18Reiterated Canaccord Genuity Buy $176 → $185
Mar-15-18Initiated Raymond James Outperform $183
Jul-31-20 12:58PM  
Jul-30-20 05:45PM  
Jul-29-20 09:16AM  
Jul-27-20 10:36AM  
Jul-23-20 12:33PM  
Jul-09-20 06:22AM  
Jul-06-20 09:03PM  
Jul-03-20 12:10PM  
Jun-29-20 07:30AM  
Jun-25-20 10:14AM  
Jun-23-20 09:46PM  
Jun-17-20 01:47PM  
Jun-11-20 10:18PM  
Jun-09-20 06:51AM  
Jun-05-20 07:58AM  
Jun-01-20 03:01AM  
May-30-20 11:31AM  
May-29-20 11:58AM  
May-27-20 03:40PM  
May-26-20 05:45PM  
May-20-20 10:18AM  
May-14-20 05:28PM  
May-13-20 01:05PM  
May-06-20 06:35AM  
May-05-20 08:00AM  
May-03-20 06:37PM  
May-01-20 03:01PM  
Apr-30-20 05:35PM  
Apr-29-20 11:15AM  
Apr-27-20 09:50AM  
Apr-23-20 12:32PM  
Apr-21-20 03:08PM  
Apr-15-20 03:26PM  
Apr-09-20 10:30AM  
Apr-07-20 08:19AM  
Apr-02-20 12:34PM  
Apr-01-20 03:53PM  
Mar-29-20 03:32PM  
Mar-27-20 06:00AM  
Mar-26-20 01:32PM  
Mar-25-20 09:03AM  
Mar-24-20 10:00AM  
Mar-23-20 10:05AM  
Mar-19-20 09:50AM  
Mar-18-20 02:06PM  
Mar-17-20 10:57AM  
Mar-16-20 10:23AM  
Mar-13-20 09:49AM  
Mar-12-20 06:39PM  
Mar-11-20 10:06AM  
Mar-10-20 12:45PM  
Mar-09-20 09:20AM  
Mar-06-20 09:53AM  
Mar-04-20 10:03AM  
Mar-02-20 11:07AM  
Feb-27-20 12:45PM  
Feb-26-20 09:21AM  
Feb-25-20 02:00PM  
Feb-24-20 11:30AM  
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boehnlein Glenn SVP, Chief Financial OfficerJun 15Sale185.2410,3511,917,37516,321Jun 17 03:24 PM
Golston Allan C.DirectorMay 29Option Exercise59.0910,465618,38718,135Jun 02 05:39 PM
Golston Allan C.DirectorMay 29Sale193.237,2991,410,3869,027Jun 02 05:39 PM
Datar Srikant M.DirectorMay 20Sale191.2540076,50016,091May 22 07:32 PM
Datar Srikant M.DirectorMay 19Option Exercise59.701,23573,73017,226May 22 07:32 PM
Datar Srikant M.DirectorMay 19Sale191.2035066,92016,491May 22 07:32 PM
Datar Srikant M.DirectorMay 08Sale194.3220038,86415,991May 08 06:59 PM
Datar Srikant M.DirectorMay 07Sale189.9950094,99516,191May 08 06:59 PM
Owen Katherine AnnVP, Strategy and IRMay 07Sale190.813,121595,5041,085May 08 05:09 PM
Owen Katherine AnnVP, Strategy and IRMay 06Option Exercise106.6612,9831,384,8048,642May 08 05:09 PM
Datar Srikant M.DirectorMay 06Option Exercise59.702,500149,25017,686May 08 06:59 PM
Datar Srikant M.DirectorMay 06Sale186.0120037,20216,691May 08 06:59 PM
Owen Katherine AnnVP, Strategy and IRMay 05Sale186.799,1491,708,9101,085May 07 09:18 PM
Doliveux RochDirectorMay 01Option Exercise0.00937022,017May 04 08:25 PM
Menon VijuGroup PresidentMay 01Option Exercise0.003,44305,622May 05 09:35 PM
Suri RajeevDirectorMay 01Option Exercise0.0093701,985May 05 09:19 PM
STRYKER RONDA EDirectorMay 01Option Exercise0.00937086,932May 05 09:05 PM
FRANCESCONI LOUISEDirectorMay 01Option Exercise0.00937017,583May 05 08:25 PM
Datar Srikant M.DirectorMay 01Option Exercise0.00937015,186May 05 08:19 PM
BRAINERD MARY KDirectorMay 01Option Exercise0.0093702,585May 05 08:13 PM
Fletcher Robert SVP, Chief Legal OfficerApr 30Option Exercise0.004,27204,272Apr 30 08:14 PM
Doliveux RochDirectorApr 30Buy190.09519,69421,080May 04 08:25 PM
Berry William E JrVP, Corporate ControllerMar 21Option Exercise0.001,32501,694Mar 24 03:53 PM
Datar Srikant M.DirectorMar 04Option Exercise59.701,00059,70014,249Mar 06 12:52 PM
Scannell Timothy JPresident and COOFeb 24Option Exercise59.7034,5552,062,934190,105Feb 25 05:19 PM
Doliveux RochDirectorFeb 06Option Exercise57.326,781388,70326,796Feb 10 03:39 PM
Doliveux RochDirectorFeb 06Sale217.873,540771,25821,029Feb 10 03:39 PM
STRYKER RONDA EDirectorFeb 03Option Exercise53.099,995530,63585,995Feb 05 09:57 AM
FRANCESCONI LOUISEDirectorJan 31Option Exercise53.099,995530,63526,641Feb 05 09:04 AM
Doliveux RochDirectorJan 31Buy216.67459,75020,912Feb 04 09:59 PM
FRANCESCONI LOUISEDirectorJan 31Sale213.657,5131,605,16316,646Feb 05 09:04 AM
Datar Srikant M.DirectorJan 29Option Exercise53.094,395233,33114,339Jan 31 03:53 PM
Datar Srikant M.DirectorDec 12Option Exercise53.091,50079,6359,944Dec 13 02:03 PM
Scannell Timothy JPresident and COONov 18Sale206.284,666962,510155,550Nov 19 12:56 PM
Scannell Timothy JPresident and COONov 15Option Exercise53.095,284280,528160,216Nov 19 12:56 PM
Datar Srikant M.DirectorNov 06Option Exercise53.091,60084,9448,444Nov 08 02:02 PM
Doliveux RochDirectorOct 31Buy216.77408,67120,867Nov 01 12:39 PM
Lobo KevinChairman and CEOOct 31Sale215.7119,2864,160,12130,478Oct 31 04:37 PM
Boehnlein Glenn SVP, Chief Financial OfficerOct 30Sale215.852,700582,79317,933Nov 01 10:50 AM
Scannell Timothy JPresident and COOOct 16Sale214.504,6661,000,839154,932Oct 17 10:59 AM
Scannell Timothy JPresident and COOOct 15Option Exercise53.095,282280,421159,598Oct 17 10:59 AM
Owen Katherine AnnVP, Strategy and IRSep 26Sale216.302,500540,7425,349Sep 30 05:55 PM
Fink M KathrynVP, Chief HR OfficerSep 19Option Exercise100.9128,6902,895,05037,837Sep 23 04:14 PM
Fink M KathrynVP, Chief HR OfficerSep 19Sale220.9728,6906,339,6129,147Sep 23 04:14 PM
Scannell Timothy JPresident and COOSep 17Sale218.514,6661,019,583154,316Sep 18 09:18 PM
Scannell Timothy JPresident and COOSep 16Option Exercise53.095,282280,421158,982Sep 18 09:18 PM
Berry William E JrVP, Corporate ControllerAug 30Sale223.20500111,600644Sep 03 09:37 AM
Scannell Timothy JPresident and COOAug 16Sale217.084,6661,012,872153,700Aug 19 11:19 AM
Scannell Timothy JPresident and COOAug 15Option Exercise53.095,282280,421158,366Aug 19 11:19 AM
Datar Srikant M.DirectorAug 15Sale215.0035075,2506,844Aug 16 11:38 AM
Datar Srikant M.DirectorAug 14Option Exercise53.092,500132,7257,800Aug 15 02:43 PM
Golston Allan C.DirectorAug 07Sale209.843,399713,2329,027Aug 07 04:52 PM
Golston Allan C.DirectorAug 05Option Exercise59.704,735282,68013,762Aug 07 04:52 PM